MARINUS PHARMACEUTICALS INC's ticker is MRNS and the CUSIP is 56854Q101. A total of 4 filers reported holding MARINUS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $317,000 | +24.8% | 124,901 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $254,000 | +53.9% | 124,901 | +63.9% | 0.00% | – |
| Q4 2019 | $165,000 | +38.7% | 76,193 | -1.4% | 0.00% | – |
| Q3 2019 | $119,000 | -62.9% | 77,258 | 0.0% | 0.00% | -100.0% |
| Q2 2019 | $321,000 | +4.9% | 77,258 | +5.7% | 0.00% | 0.0% |
| Q1 2019 | $306,000 | +91.2% | 73,111 | +31.2% | 0.00% | – |
| Q4 2018 | $160,000 | -71.3% | 55,718 | 0.0% | 0.00% | -100.0% |
| Q3 2018 | $557,000 | +41.4% | 55,718 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $394,000 | – | 55,718 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 1,192,883 | $15,329,000 | 3.00% |
| Bain Capital Life Sciences Investors, LLC | 1,431,059 | $18,389,000 | 1.71% |
| Avoro Capital Advisors LLC | 3,000,000 | $38,550,000 | 0.55% |
| Palo Alto Investors LP | 31,330 | $403,000 | 0.02% |